MCQs on "Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes" Answers with Explanations and References

被引：0
|
作者：
不详
机构：
来源：
INDIAN JOURNAL OF CANCER | 2020年 / 57卷 / 02期
关键词：
ESTROGEN-RECEPTOR; CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：198 / 200
页数：3
相关论文
共 50 条
  • [1] Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes
    Khande, Tejal Abasaheb
    Joshi, Avinash R.
    Khandeparkar, Siddhi Gaurish Sinai
    Kulkarni, Maithili M.
    Gogate, Bageshri P.
    Kakade, Aniket R.
    Sahu, Piyush D.
    Khillare, Chaitnya D.
    INDIAN JOURNAL OF CANCER, 2020, 57 (02) : 190 - 197
  • [2] Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
    Peng, Jian-Heng
    Zhang, Xiang
    Song, Jun-Long
    Ran, Liang
    Luo, Rong
    Li, Hong-Yuan
    Wang, Yong-Hong
    MEDICINE, 2019, 98 (02)
  • [3] Expression of ER/PR Receptor, Her-2/neu, Ki67 and p53 in Endometrial Carcinoma: Clinicopathological Implication and Prognostic Value
    V. B. Shivkumar
    Manisha A. Atram
    Nitin M. Gangane
    Indian Journal of Gynecologic Oncology, 2020, 18
  • [4] Expression of ER/PR Receptor, Her-2/neu, Ki67 and p53 in Endometrial Carcinoma: Clinicopathological Implication and Prognostic Value
    Shivkumar, V. B.
    Atram, Manisha A.
    Gangane, Nitin M.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 18 (03)
  • [5] Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes Retrospective-Observational Analytical Study
    Shokouh, Taghipour Zahir
    Ezatollah, Aalipour
    Barand, Poorya
    MEDICINE, 2015, 94 (32)
  • [6] Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma
    Garcia-Velasco, Adelaida
    Mendiola, Cesar
    Sanchez-Munoz, Alfonso
    Ballestin, Claudio
    Colorner, Ramon
    Cortes-Funes, Hernan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (06): : 367 - 371
  • [7] Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma
    Adelaida García-Velasco
    César Mendiola
    Alfonso Sánchez-Muñoz
    Claudio Ballestín
    Ramón Colomer
    Hernán Cortés-Funes
    Clinical and Translational Oncology, 2008, 10
  • [8] EXPRESSION OF ER, PR, P53, AND KI67 IN NONPROLIFERATIVE, HYPERPLASTIC AND MALIGNANT APOCRINE LESIONS OF THE BREAST
    TAVASSOLI, FA
    MAN, YG
    LABORATORY INVESTIGATION, 1995, 72 (01) : A26 - A26
  • [9] HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer
    Norbert Arens
    Uwe Bleyl
    Ralf Hildenbrand
    Virchows Archiv, 2005, 446 : 489 - 496
  • [10] HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer
    Arens, N
    Bleyl, U
    Hildenbrand, R
    VIRCHOWS ARCHIV, 2005, 446 (05) : 489 - 496
12345